Sempresto

The Always There autoinjector, on your phone

https://wefunder.com/sempresto

Total raised on Wefunder: 512000

Total investors: 48

Quick facts

  • Backed by $2.6M angel investment and Jefferson University Partnership
  • FDA filing targeted within 18 months, with no clinical trials required
  • Medtech leadership team trained at Harvard, MIT, Wharton, Johns Hopkins & UPenn Medicine
  • 15 patents granted, 10 pending across phone-based autoinjector technology (US & ex-US)
  • Targeting a $3B+ addressable market; 33M Americans living with food allergies
  • World-class team with 3 IPOs and 30+ commercial product launches
  • 85%+ projected gross margins at scale, priced below the current market average (not guaranteed)
  • Innovative autoinjector designed to attach to a smartphone, compatible with 95% of phones

Team profiles

Featured investor profiles

Invest in Sempresto

The Always There autoinjector, on your phone

EARLY BIRD TERMS: $101,799 LEFT

$512,000

of a $750,000 goal
INVESTMENT TERMS
Preferred Stock
 $14.9M  $11.8M pre-money valuation  $1.08  $0.86 per share
Early Bird Bonus: The first $123K of investments will be at $0.86 per share and a $11.8M pre-money valuation

What Investors Say

LEAD INVESTOR
Invested $100,000 this round + $2,500,000 previously
My relationship with Sempresto is based on my relationship with Dr. Pribitkin. Dr. Pribitkin was involved in a complicated set of surgeries for my son, where he was the lead surgeon and basically quarterbacked the entire day of operations. I’ll never forget his concern, care and commitment to drive a successful outcome for my son. When he approached me with his vision for Sempresto I knew he’d provide that same level of concern, care and commitment to achieve a successful solution. Doctor Pribitkin has assembled an exceptional team that brings the ability to turn his vision into a real product opportunity. The team is experienced, committed and competent. They have developed a functional prototype, build a strong intellectual property portfolio and establish a clear path towards manufacturing and regulatory approval. Having spent my career building and leading businesses, I understand how difficult it is to translate a transformative idea into something tangible. This exceptional team has the ability to execute with focus, commitment and determination. Sempresto still has important work ahead but I believe the team has the passion, experience and commitment to make this product a reality. I’m excited to support them and to see Sempresto become a potentially life-saving innovation to patients and families.
What People Say